Diabetes and Macular Degeneration are more treatable than ever.
Annual incidence is <1/1,000,000 in the UK, approximately 80% of cases occur in males.
CD onset predominantly occurs in male children between 6 and 8 years old. Early stages of the disease are generally asymptomatic and evolution is variable. As children with unilateral vision loss usually do not complain of symptoms, the diagnosis is often based on an abnormal appearance of the pupillary reflex that can best be seen in photos or on red reflex testing. Other common presentations include the onset of strabismus or failure of a school vision screening examination. Ophthalmoscopy reveals unilateral retinal telangiectasia and aneurysms of the retinal vasculature. This is followed by exudation of fluids producing yellow subretinal deposits. The most advanced stages of CD include total retinal detachment, leukocoria and painful glaucoma secondary to angle closure.
An abnormal permeability of capillary endothelial cells in the retina, along with abnormal pericytes, causes the retinal vascular leakage that is the hallmark of CD. CD is not heritable, however, somatic mutations in the Norrie Disease Pseudoglioma, NDP, gene have been hypothesized to play a role in the pathogenesis of CD.
Diagnostic methods include indirect ophthalmoscopy, fluorescein angiography, ultrasonography, computerized tomography scanning and magnetic resonance imaging.
Retinoblastoma (see this term) is the most important differential diagnosis. B-scan ultrasound and MRI with gadolinium contrast aid in distinguishing between late stage CD and solid tumors. Others include familial exudative vitreoretinopathy, Von Hippel-Lindau disease, intermediate uveitis and incontinentia pigmenti which are more often bilateral, as well as the more typically unilateral conditions such as ocular toxocariasis and persistent hyperplastic primary vitreous (see these terms).
Treatment depends on severity of disease. Mild peripheral vascular abnormalities may be followed with serial fundus photography. When exudation is present, ablation of incompetent vessels and avascular retina should be performed using laser or less often, cryotherapy. More advanced cases can require surgical intervention for retinal reattachment, such as scleral buckling, or laser photocoagulation combined with pars plana vitrectomy and removal of the vitreous membrane. Intravitreal corticosteroid as well as anti-VEGF agents have been used as adjuvant therapies.
The majority of cases stabilize with proper therapy, although exudation and macular scarring commonly compromise vision. A retrospective study showed that 16% of patients had a final visual acuity of 20/50 or better and 47% had hand motions to no light perception in the affected eye. Approximately 20% of eyes may require enucleation.
Expert reviewer(s): Dr Baker HUBBARD - Dr Philip LAIRD - Last update: July 2013
Nikolas J.S. London, ... Julia A. Haller, in Retina (Fifth Edition), 2013
Coats disease is an idiopathic condition characterized by telangiectatic and aneurysmal retinal vessels with intraretinal and subretinal exudation and fluid.1 Coats disease was first described by Scottish ophthalmologist George Coats in 1908.2 In his initial classification, Coats separated this new entity into three distinct groups. Group I included eyes with massive subretinal exudation and no demonstrable vascular abnormalities. Group II consisted of eyes with massive subretinal exudation and multiple retinal vascular abnormalities with intraretinal hemorrhage. Group III included eyes with massive subretinal exudation and frank retinal arteriovenous malformations.2 Eugen von Hippel later demonstrated that group III represented the distinctly separate entity of angiomatosis retinae (later retermed retinal capillary hemangioma or retinal hemangioblastoma), prompting Coats to drop this group from his classification. In 1912, and again in 1915, Theodor von Leber described a disease with similar telangiectatic and aneurysmal retinal vessels that lacked the massive subretinal exudation described by Coats.3,4 This condition was later named Leber multiple miliary aneurysms. In a 1916 paper, Leber concluded that what he had described was merely an earlier stage of the disease process identified by Coats.5,6 This conclusion was later reinforced by Reese, who described an eye with Leber miliary aneurysms that progressed into a classic case of Coats disease during long-term follow-up.7Although some authors have disagreed, most authorities today classify Leber disease as an early or nonprogressive form of Coats disease.5,8,9
Copyright © 2005-2024 The Retina Institute — All Rights Reserved.
Most insurance accepted. Care Credit available.